nach oben

Erschienen in:

21.09.2015

Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat

verfasst von: Kais Mnafgui, Raouf Hajji, Fatma Derbali, Anis Gammoudi, Gaddour Khabbabi, Hedi Ellefi, Noureddine Allouche, Adel Kadri, Neji Gharsallah

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to evaluate the antithrombotic, anti-inflammatory and anti-cardiac remodeling properties of eugenol in isoproterenol-induced myocardial infarction in rats. Male Wistar rats were randomly divided into four groups, control, iso [100 mg/kg body weight was injected subcutaneously into rats at an interval of 24 h for 2 days (6th and 7th day) to induce MI] and pretreated animals with clopidogrel (0.2 mg/kg) and eugenol (50 mg/kg) orally for 7 days and intoxicated with isoproterenol (Iso + Clop) and (Iso + EG) groups. Isoproterenol-induced myocardial infarcted rats showed notable changes in the ECG pattern, increase in heart weight index, deterioration in the hemodynamic function and rise in plasma level of troponin-T, CK-MB and LDH and ALT by 316, 74, 172 and 45 %, respectively, with histological myocardium necrosis and cells inflammatory infiltration. In addition, significant increases in plasma levels of inflammatory biomarkers such as fibrinogen, α1, α2, β1, β2 and γ globulins with decrease level of albumin were observed in infarcted rats as compared to normal ones. Else, the angiotensin-converting enzyme (ACE) activity in plasma, kidney and heart of the isoproterenol-induced rats was significantly increased by 34, 47 and 93 %, respectively, as compared to normal group. However, the administration of eugenol induced a clear improvement in cardiac biomarkers injury, reduced inflammatory mediators proteins, increased heart activities of superoxide dismutase and glutathione peroxidase with reduce in thiobarbituric acid-reactive substances content and inhibition of ventricular remodeling process through inhibition of ACE activity. Overall, eugenol evidences high preventive effects from cardiac remodeling process.

White, M. Y., Edwards, A. G., Cordwell, S. J., & Van Eyk, J. E. (2008). Mitochondria: A mirror into cellular dysfunction in heart disease. Proteomics-Clinical Applications, 2, 845–861.CrossRefPubMed

Ross, R. (1999). Atherosclerosis-an inflammatory disease. New England Journal of Medicine, 340, 115–126.CrossRefPubMed

Hong, M. K., Mintz, G. S., Lee, C. W., Kim, Y. H., Lee, S. W., Song, J. M., et al. (2004). Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients. Circulation, 110, 928–933.CrossRefPubMed

Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet, 367, 1747–1757.CrossRefPubMed

Cohn, J. N., Ferrari, R., & Sharpe, N. (2000). Cardiac remodeling—concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. Journal of the American College of Cardiology, 35, 569–582.CrossRefPubMed

Salloum, F. N., Abbate, A., Das, A., Houser, J. E., Mudrick, C. A., Qureshi, I. Z., et al. (2008). Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. American Journal of Physiology: Heart and Circulation Physiology, 294, 398–406.

Mnafgui, K., Hajji, R., Derbali, F., Khlif, I., Kraiem, F., Ellefi, H., et al. (2015). Protective effect of hydroxytyrosol against cardiac remodeling after isoproterenol-induced myocardial infarction in rat. Cardiovascular Toxicology. doi:10.1007/s12012-015-9323-1.PubMed

Borghi, C., Bacchelli, S., Esposti, D. D., & Ambrosioni, E. (2006). Effects of early angiotensin-converting enzyme inhibition in patients with non–ST-elevation acute anterior myocardial infarction. American Heart Journal, 152, 470–477.CrossRefPubMed

Mnafgui, K., Khlif, I., Hajji, R., Derbali, F., Kraiem, F., Ellefi, H., et al. (2015). Preventive effects of oleuropein against cardiac remodeling after myocardial infarction in Wistar rat through inhibiting angiotensin-converting enzyme activity. Journal of Toxicology Mechanisms and Methods. doi:10.3109/15376516.2015.1053648.PubMed

10.

Srinivasan, S., Sathish, G., Jayanthi, M., Muthukumaran, J., Muruganathan, U., & Ramachandran, V. (2014). Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin induced diabetic rats. Journal of Molecular and Cellular Biochemistry, 385, 159–168.CrossRefPubMed

11.

Mnafgui, K., Kaanich, F., Derbali, A., Hamden, K., Derbali, F., Slama, S., et al. (2013). Inhibition of key enzymes related to diabetes and hypertension by eugenol in vitro and in alloxan-induced diabetic rats. Archive of Physiology and Biochemistry, 119, 225–233.CrossRef

12.

Fraga, C. G., Leibovitz, B. E., & Toppel, A. L. (1988). Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes. Free Radical Biology and Medicine, 4, 155–161.CrossRefPubMed

13.

Kakkar, P., Das, B., & Viswanathan, P. N. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry & Biophysics, 21, 130–132.

14.

Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., & Hoekstra, W. G. (1973). Selenium: Biochemical role as a component of glutathione peroxidase. Science, 179, 588–590.CrossRefPubMed

15.

Kannan, M. M., & Quine, S. D. (2011). Ellagic acid ameliorates isoproterenol induced oxidative stress: Evidence from electrocardiological, biochemical and histological study. European Journal of Pharmacology, 659, 45–52.CrossRefPubMed

16.

Whalen, E. J., & Lewis, S. J. (1999). In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac b1-or b2-adrenoceptors. European Journal of Pharmacology, 382, 207–210.CrossRefPubMed

17.

Upaganlawar, A., Gandhi, H., & Balaraman, R. (2011). Isoproterenol induced myocardial infarction: Protective role of natural products. Journal of Pharmacology and Toxicology, 6, 1–17.

18.

Damiania, E. N., Rossonia, L. V., & Vassalloa, D. V. (2003). Vasorelaxant effects of eugenol on rat thoracic aorta. Vascular Pharmacology, 40, 59–66.CrossRef

19.

Choudhary, R., Mishra, K. P., & Subramanyam, C. (2006). Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant. Indian Journal of Clinical Biochemistry, 21, 107–113.CrossRefPubMedPubMedCentral

20.

Lahlou, S., Interaminense, L. F. L., Magalhães, P. J. C., Leal-Cardoso, J. H., & Duarte, G. P. (2004). Cardiovascular effects of eugenol, a phenolic compound present in many plant essential oils, in normotensive rats. Journal of Cardiovascular Pharmacology, 43, 250–257.CrossRefPubMed

21.

Gasparyan, A. Y. (2012). Cardiovascular risk and inflammation: Pathophysiological mechanisms, drug design, and targets. Current Pharmaceutical Design, 18, 1447–1449.CrossRefPubMed

22.

Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000). Markers of myocardial damage and inflammation in relation to long term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in Coronary Artery Disease. New England Journal of Medicine, 343, 1139–1147.CrossRefPubMed

23.

Biasucci, L. M., Liuzzo, G., Grillo, R. L., Caligiuri, G., Rebuzzi, A. G., Buffon, A., et al. (1999). Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 99, 855–860.CrossRefPubMed

24.

Maresca, G., Di Blasio, A., Marchioli, R., & Di Minno, G. (1999). Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1368–1377.CrossRefPubMed

25.

De Sutter, J., De Buyzere, M., Gheeraert, P., Van de Wiele, C., Voet, J., De Pauw, M., et al. (2001). Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis, 157, 189–196.CrossRefPubMed

26.

Lubrano, V., & Balzan, S. (2015). Consolidated and emerging inflammatory markers in coronary artery disease. World Journal of Experimental Medicine, 5, 21–32.CrossRefPubMedPubMedCentral

27.

Badimon, L., Chesebro, J. H., & Badimon, J. J. (1992). Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation, 86, 74–85.

28.

Reinhart, W. H. (2003). Fibrinogen -marker or mediator of vascular disease? Vascular Medicine, 8, 211–216.CrossRefPubMed

29.

Coppola, G., Rizzo, M., Abrignani, M. G., Corrado, E., Di Girolamo, A., Braschi, A., et al. (2005). Fibrinogen as a predictor of mortality after acute myocardial infarction: A forty-two-month follow-up study. Italian Heart Journal, 6, 315–322.PubMed

30.

Kannan, M. M., & Quine, D. S. (2013). Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism, 62, 52–61.CrossRefPubMed

31.

Grobe, J. L., Mecca, A. P., Mao, H., & Katovich, M. G. (2006). Chronic angiotensin (1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension. American Journal of Physiology: Heart and Circulation Physiology, 290, 2417–2423.

32.

Border, W. A., & Noble, N. A. (1994). Transforming growth factor β in tissue fibrosis. New England Journal of Medicine, 331, 1286–1292.CrossRefPubMed

33.

Roy, S. G., & Prince, S. M. (2013). Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. European Journal of Pharmacology, 699, 213–218.CrossRefPubMed

34.

Becker, L. B. (2004). New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovascular Research, 61, 461–470.CrossRefPubMed

35.

Ito, M., Murakami, K., & Yoshino, M. (2005). Antioxidant action of eugenol compounds: Role of metal ion in the inhibition of lipid peroxidation. Food and Chemical Toxicology, 43, 461–466.CrossRefPubMed

Titel: Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat
verfasst von: Kais Mnafgui
Raouf Hajji
Fatma Derbali
Anis Gammoudi
Gaddour Khabbabi
Hedi Ellefi
Noureddine Allouche
Adel Kadri
Neji Gharsallah
Publikationsdatum: 21.09.2015
Verlag: Springer US
Erschienen in: Cardiovascular Toxicology / Ausgabe 4/2016
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-015-9343-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence

Prenatal Exposure to Phthalic Acid Induces Increased Blood Pressure, Oxidative Stress, and Markers of Endothelial Dysfunction in Rat Offspring

NF-κB Blockade in Hypothalamic Paraventricular Nucleus Inhibits High-Salt-Induced Hypertension Through NLRP3 and Caspase-1

Drug Resistance of Endocardial Endothelial Cells is Related to Higher Endogenous ABCG2

Effects of 2-Hydroxypropyl-Beta-Cyclodextrin on Cardiovascular Signs of Amitriptyline Poisoning in a Rat Model

Cardiomyopathy from 1,1-Difluoroethane Inhalation